Debra K. Osteen - 12 Dec 2023 Form 4 Insider Report for Acadia Healthcare Company, Inc. (ACHC)

Role: Director
Signature: /s/ Brian Farley as Attorney in Fact for Debra K. Osteen
Issuer symbol: ACHC
Transactions as of: 12 Dec 2023
Net transactions value: -$3,328,290
Form type: 4
Filing time: 14 Dec 2023, 21:14:12 UTC
Previous filing: 13 Nov 2023
Next filing: 21 Jan 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACHC	Common Stock	Sale	$609,840	-8,000	-1.1%	$76.23	710,833	12 Dec 2023	Direct	F1
transaction	ACHC	Common Stock	Sale	$2,718,450	-35,000	-4.9%	$77.67	675,833	13 Dec 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.2013 to $76.2501, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.0203 to $78.47, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.2013 to $76.2501, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.0203 to $78.47, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.